|
Market Cap (5-Jul) $37,640,252 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (19-Jun) 470,735 (0.11%) (418th) |
|
52w High $0.130 |
52w Low $0.082 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 28 February 2023, 9:29. The announcement is marked as price sensitive, and is 23 page(s) in length and 1.2MB in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 1.066% short sold according to ASIC data. It was ranked the 191st most shorted stock on the ASX. It remains ranked 418th as of the latest reported data (19 June 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Interim Report and Half-Year Financial Results | 28 February 2023, 9:29 |
| Dr Russell Basser appointed as director and Appendix 3X | 20 February 2023, 14:16 |
| Change in substantial holding | 10 February 2023, 17:15 |
| Change in substantial holding | 10 February 2023, 8:22 |
You must be logged in to post a reply.
Starpharma Holdings 